RT Journal Article
SR Electronic
T1 COVID-19 L·OVE REPOSITORY IS HIGHLY COMPREHENSIVE AND CAN BE USED AS A SINGLE SOURCE FOR COVID-19 STUDIES
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.21.21263849
DO 10.1101/2021.09.21.21263849
A1 Verdugo-Paiva, F
A1 Vergara, C
A1 Ávila, C
A1 Castro, J
A1 Cid, J
A1 Contreras, V
A1 Jara, I
A1 Jiménez, V
A1 Lee, MH
A1 Muñoz, M
A1 Rojas Gómez, AM
A1 Rosón-Rodríguez, P
A1 Serrano-Arévalo, K
A1 Silva-Ruz, I
A1 Vásquez-Laval, J
A1 Zambrano-Achig, P
A1 Zavadzki, G
A1 Rada, G
YR 2021
UL http://medrxiv.org/content/early/2021/09/27/2021.09.21.21263849.abstract
AB Objective COVID-19 Living OVerview of Evidence (COVID-19 L·OVE) is a public repository and classification platform for COVID-19 articles. The repository contains over 430,000 articles as of 20 September 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews.Methods Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L·OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L·OVE repository. We estimated the currency as the percentage of studies that were available in the COVID-19 L·OVE repository at the time the systematic reviews conducted their own search.Results We identified 83 eligible systematic reviews that included 2132 studies. COVID-19 L·OVE had an overall comprehensiveness of 99.67% (2125/2132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L·OVE instead of searching the original sources, was 96.48% (2057/2132). Both the comprehensiveness and the currency were 100% for randomised trials (82/82).Conclusion The COVID-19 L·OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processesCompeting Interest StatementCOVID-19 L-OVE was developed and is maintained by Epistemonikos Foundation, a non-profit organisation with a strict policy to avoid financial conflict of interests. Details about this policy and financial support can be found on the website of the Foundation (http://www.epistemonikos.cl). All authors, as creators, developers or contributors, have some degree of academic conflict of interests with this article.Funding StatementThe authors received no financial support for the research, authorship, and/or publication of this article. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This article does not report on or involve the use of any animal or human data or tissue, so this section is not applicable. Details about the Terms and Conditions can be accessed at https://www.epistemonikos.org/en/terms_and_conditions All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and analysed during the current study or datasets needed to reproduce the results of this study (e.g. a list of included/excluded records) are available from the corresponding author on reasonable request.